JournalTOCs

Publisher: Ivy Union Publishing (Total: 5 journals) [Sort by number of followers]

Showing 1 - 5 of 5 Journals sorted alphabetically
	American J. of Cancer Case Reports (Followers: 4)
	American J. of Cancer Science (Followers: 3)
	American J. of Current Microbiology (Followers: 5)
	American J. of Energy and Environment (Followers: 6)
	American J. of Polymer Science & Engineering (Followers: 2)

Most Followed Journals

Top Publishers

Top Subjects

Similar Journals

American Journal of Polymer Science & Engineering
Number of Followers: 2

This is an Open Access Journal

Open Access journal
ISSN (Online) 2572-5734
Published by Ivy Union Publishing

[5 journals]

Localization matters in targeted protein degradation
- Authors: Varun Jayeshkumar Shah; Ivan Đikić
  Pages: 1465 - 1466
  Abstract: Many factors influence the efficiency of targeted protein degradation induced by proteolysis targeting chimeras (PROTACs). In this issue of Cell Chemical Biology, Simpson et al. (2022) highlight the impact of subcellular localization. Their study elucidates that the protein of interest exhibits different amenability to PROTAC-mediated degradation at different cellular compartments.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-10-20
  DOI: 10.1016/j.chembiol.2022.09.006
  Issue No: Vol. 29, No. 10 (2022)
Fishing for a balance: Toward promyelinating drug discovery
- Authors: Hannah Y. Collins; Ben Emery
  Pages: 1467 - 1469
  Abstract: In this issue, Häberlein et al. demonstrate a role for GPR17 in regulating zebrafish oligodendrocyte differentiation. Zebrafish expressing a humanized GPR17 respond to modulators, which are inactive against the endogenous zebrafish receptor. These findings highlight the potential for humanized zebrafish as an in vivo platform for targeted remyelination drug screens.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-10-20
  DOI: 10.1016/j.chembiol.2022.09.005
  Issue No: Vol. 29, No. 10 (2022)
Exploring the target scope of KEAP1 E3 ligase-based PROTACs
- Authors: Guangyan Du; Jie Jiang, Nathaniel J. Henning, Nozhat Safaee, Eriko Koide, Radosław P. Nowak, Katherine A. Donovan, Hojong Yoon, Inchul You, Hong Yue, Nicholas A. Eleuteri, Zhixiang He, Zhengnian Li, Hubert T. Huang, Jianwei Che, Behnam Nabet, Tinghu Zhang, Eric S. Fischer, Nathanael S. Gray
  Pages: 1470 - 1481.e31
  Abstract: Du et al. explores a variety of bivalent KEAP1-recruiting degraders to assess the generality of KEAP as an E3 ligase for targeted protein degradation They found the targets easily degraded using a cereblon (CRBN)- or VHL-recruiting degrader were refractory to KEAP1-mediated degradation.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-09-06
  DOI: 10.1016/j.chembiol.2022.08.003
  Issue No: Vol. 29, No. 10 (2022)
Target protein localization and its impact on PROTAC-mediated degradation
- Authors: Luke M. Simpson; Lorraine Glennie, Abigail Brewer, Jin-Feng Zhao, Jennifer Crooks, Natalia Shpiro, Gopal P. Sapkota
  Pages: 1482 - 1504.e7
  Abstract: Simpson et al. interrogate how the subcellular context of a target protein influences its amenability to PROTAC-mediated degradation. Differentially localized proteins displayed varying levels of degradation using the same respective PROTACs, suggesting that the subcellular context of the target protein can influence the efficacy of PROTAC-mediated POI degradation.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-09-07
  DOI: 10.1016/j.chembiol.2022.08.004
  Issue No: Vol. 29, No. 10 (2022)
A propeptide-based biosensor for the selective detection of Vibrio
cholerae using an environment-sensitive fluorophore
- Authors: Alicia A. DeColli; Isabel M. Koolik, Anna B. Seminara, Stavroula K. Hatzios
  Pages: 1505 - 1516.e7
  Abstract: Proteases are attractive biomarkers for diagnostic applications, but identifying peptide substrates specific to a targeted pathogen is challenging. DeColli et al. demonstrate that the propeptide domain of a secreted bacterial protease can be engineered into a cleavage-based biosensor of the cholera pathogen Vibrio cholerae.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-10-20
  DOI: 10.1016/j.chembiol.2022.09.003
  Issue No: Vol. 29, No. 10 (2022)
Targeting telomerase reverse transcriptase with the covalent inhibitor
NU-1 confers immunogenic radiation sensitization
- Authors: Yue Liu; Rick C. Betori, Joanna Pagacz, Grant B. Frost, Elena V. Efimova, Ding Wu, Donald J. Wolfgeher, Tracy M. Bryan, Scott B. Cohen, Karl A. Scheidt, Stephen J. Kron
  Pages: 1517 - 1531.e7
  Abstract: Liu et al. use telomerase inhibitor NU-1 to further implicate TERT in promoting DNA repair and cell survival after radiation in vitro. In vivo, NU-1 sensitizes tumors to radiation not only by blocking DNA repair but also by potentiating an adaptive immune response that leads to tumor elimination.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-10-06
  DOI: 10.1016/j.chembiol.2022.09.002
  Issue No: Vol. 29, No. 10 (2022)
Dimerization of β2-adrenergic receptor is responsible for the
constitutive activity subjected to inverse agonism
- Authors: Yonghoon Kwon; Do-Hyeon Kim, Min Gyu Jeong, Minh-Triet Hong, Soyeon Park, Yeonho Chang, Kai Zhou, Seung-Yeol Park, Jin Zhang, Sung Ho Ryu
  Pages: 1532 - 1540.e5
  Abstract: Kwon et al. visualized transient β2-AR dimerization in living cells. A significant amount of β2-AR dimers exist in the basal state, and these were disrupted by inverse agonists. Gαs proteins couple to the dimeric β2-AR in basal state, resulting in cAMP production. The formation of β2-AR dimers requires cholesterol on the plasma membrane.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-09-26
  DOI: 10.1016/j.chembiol.2022.09.001
  Issue No: Vol. 29, No. 10 (2022)
Humanized zebrafish as a tractable tool for in vivo evaluation of
pro-myelinating drugs
- Authors: Felix Häberlein; Enrico Mingardo, Nicole Merten, Nina-Katharina Schulze Köhling, Philip Reinoß, Katharina Simon, Anna Japp, Bhuvaneswari Nagarajan, Ramona Schrage, Cecile Pegurier, Michel Gillard, Kelly R. Monk, Benjamin Odermatt, Evi Kostenis, Jesus Gomeza
  Pages: 1541 - 1555.e7
  Abstract: The identification of drugs that promote remyelination in patients with demyelinating diseases, such as multiple sclerosis, is in high demand. Häberlein et al. introduce a GPR17-humanized zebrafish as proof of principle that fosters in vivo identification of novel pro-remyelination compounds acting via targeted inhibition of human GPR17.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-09-19
  DOI: 10.1016/j.chembiol.2022.08.007
  Issue No: Vol. 29, No. 10 (2022)
In vivo bioluminescence imaging of granzyme B activity in tumor response
to cancer immunotherapy
- Authors: Min Chen; Kaixiang Zhou, Sheng-Yao Dai, Sirimuvva Tadepalli, Preethi Bala Balakrishnan, Jinghang Xie, Fadi E.I. Rami, Tingting Dai, Liyang Cui, Juliana Idoyaga, Jianghong Rao
  Pages: 1556 - 1567.e6
  Abstract: Chen et al. report the first granzyme B-activated bioluminescent probe GBLI-2 for non-invasive, real-time, and longitudinal imaging in vivo. GBLI-2 imaging predicts therapeutic efficacy and correlates with the change in the population of PD-1 and granzyme B expressing CD8+ T cells in tumors.
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-09-13
  DOI: 10.1016/j.chembiol.2022.08.006
  Issue No: Vol. 29, No. 10 (2022)
Context-dependent regulation of ferroptosis sensitivity
- Authors: Leslie Magtanong; Grace D. Mueller, Kevin J. Williams, Maximilian Billmann, Katherine Chan, David A. Armenta, Lauren E. Pope, Jason Moffat, Charles Boone, Chad L. Myers, James A. Olzmann, Steven J. Bensinger, Scott J. Dixon
  First page: 1568
  Abstract: (Cell Chemical Biology 29, 1–10.e1–e6; September 15, 2022)
  Citation: Cell Chemical Biology 29, 10 (2022)
  PubDate: 2022-10-20
  DOI: 10.1016/j.chembiol.2022.08.008
  Issue No: Vol. 29, No. 10 (2022)